Claire Fraser-Liggett

Claire M.
Fraser-Liggett is currently an Independent Director at Waters Corp.
since 2026, an Independent Director at Seres Therapeutics, Inc. since 2023, a Trustee at Rensselaer Polytechnic Institute, a Professor at the University of Maryland Medical Center since 2007, and a Member of the National Academy of Medicine since 2011.
Former positions include Director at Helicos Biosciences Corp., President & Director at the Institute for Genomic Research from 1998 to 2007, President-Elect & Director at the American Association for the Advancement of Science, Director at the Institute For Genome Sciences from 2007 to 2024, Director at Ohana Biosciences, Inc., Independent Director at Becton, Dickinson & Co. from 2006 to 2026, Trustee at the Institute for Defense Analyses, and Professor-Medicine, Microbiology & Immunology at the University of Maryland School of Medicine.
Education includes undergraduate studies at Rensselaer Polytechnic Institute and a doctorate from the State University of New York at Buffalo.